These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 7011783

  • 1. Evaluation of a spironolactone and althiazide combination (aldactacine) in Africans with benign essential hypertension.
    Pinto JM.
    East Afr Med J; 1981 Jan; 58(1):44-50. PubMed ID: 7011783
    [No Abstract] [Full Text] [Related]

  • 2. The use of a spironolactone and althiazide combination (aldactacine) in the treatment of benign essential hypertension.
    Mngola EN.
    J Int Med Res; 1980 Jan; 8(3):199-204. PubMed ID: 6993252
    [Abstract] [Full Text] [Related]

  • 3. [Spironolactone-thiazides-reserpine. Antihypertensive effect in essential arterial hypertension].
    de los Rios JC, Ortíz Feijoo J, Otero Cagide F.
    Prensa Med Mex; 1976 Jan; 41(7-8):210-4. PubMed ID: 796845
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of benign essential hypertension with an association of spironolactone and thiabutazide: an open multicenter study in general practice (author's transl)].
    Rhomberg F, Leya A.
    Schweiz Rundsch Med Prax; 1981 Dec 08; 70(50):2269-78. PubMed ID: 7031639
    [No Abstract] [Full Text] [Related]

  • 5. A comparative evaluation of aldactide and methyldopa in the management of benign essential hypertension.
    Nair KG, Jairam HN, Lal HM, Phaterpekar SJ.
    J Assoc Physicians India; 1980 Dec 08; 28(1-2):7-13. PubMed ID: 7216969
    [No Abstract] [Full Text] [Related]

  • 6. [Aldactazide].
    de Roquefeuil F, Goupil C.
    Soins Cardiol; 1986 Jan 08; (35):I-II. PubMed ID: 3634504
    [No Abstract] [Full Text] [Related]

  • 7. Step 1 1/2 therapy for the treatment of hypertension.
    Miller SA, Cobb SD, Petrulis AS, Vertes V.
    Ohio State Med J; 1985 Jan 08; 81(1):57, 59-61, 63. PubMed ID: 3881712
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of essential arterial hypertension with a thiazide-spironolactone-reserpine derivative combination].
    Klepping C, Villand J.
    J Med Lyon; 1971 Sep 20; 52(213):1139-41. PubMed ID: 4400152
    [No Abstract] [Full Text] [Related]

  • 9. A clinical trial of a spironolactone/thiazide combination in the treatment of hypertension in Zambian Africans.
    Levitt D.
    Curr Med Res Opin; 1979 Sep 20; 6(2):136-41. PubMed ID: 380911
    [No Abstract] [Full Text] [Related]

  • 10. Spiroprop (spironolactone + propranolol) for hypertension.
    Drug Ther Bull; 1985 Apr 22; 23(8):31-2. PubMed ID: 3996214
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical tests with a new antihypertensive combination (Bendigon)].
    Hesseling W.
    Med Welt; 1970 Sep 12; 37():1621-5. PubMed ID: 5526792
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical trial of an antihypertensive agent: antipressin].
    Warembourg H, Théry C.
    Lille Med; 1967 Feb 12; 12(2):Suppl:143-6. PubMed ID: 5623385
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical study of an antihypertensive combination].
    Leng-Lévy J, Aubertin J, Leng B, Mayeux A.
    Bord Med; 1972 Jun 12; 5(12):1487-9. PubMed ID: 4651175
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of hypertension in mild kidney insufficiency].
    Schrey A, Hartmann H, Jutzler GA, Grund R, Forst HT.
    Ther Ggw; 1982 Aug 12; 121(8):465-75. PubMed ID: 6753222
    [No Abstract] [Full Text] [Related]

  • 15. Spironolactone and hydroflumethiazide in the treatment of hypertension.
    Akbar FA, Boston PF, Chapman J, Pearce MY.
    Br J Clin Pract; 1981 Sep 12; 35(9):317-21. PubMed ID: 7034762
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical studies with a new antihypertensive agent, Bendigon].
    Wardemann H.
    Med Welt; 1970 Sep 12; 37():1617-20. PubMed ID: 5526791
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of essential hypertension with baronorm. Results of an experimentation on 35 cases].
    Menechet F, Fontanille P.
    Bord Med; 1972 Apr 12; 5(7):851-4. PubMed ID: 5055353
    [No Abstract] [Full Text] [Related]

  • 18. [Value of successive use of aldactone and aldactacine in the management of congestive heart failure involving at the outset hypokalemia with or without cardiac rhythm disorders].
    Koate P, Diouf S, Sylla M, Diop G, Diop SN.
    Dakar Med; 1981 Apr 12; 26(1):1-11. PubMed ID: 7238279
    [No Abstract] [Full Text] [Related]

  • 19. Differential effect of hypotensive drugs on renal and steroid hypertensive rats.
    Willard PW, Beckhelm GA.
    Arch Int Pharmacodyn Ther; 1968 May 12; 173(1):11-5. PubMed ID: 5657813
    [No Abstract] [Full Text] [Related]

  • 20. [A new hypotensive agent: FH109C. Apropos of 32 cases].
    Gilgenkrantz JM, Hua G, Weiller M, Polu JM, Mayer G.
    Presse Med (1893); 1971 Jan 23; 79(4):151-2. PubMed ID: 4395623
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.